Submitted: 07 Jul 2019
Accepted: 23 Apr 2019
First published online: 05 May 2019
EndNote EndNote

(Enw Format - Win & Mac)

BibTeX BibTeX

(Bib Format - Win & Mac)

Bookends Bookends

(Ris Format - Mac only)

EasyBib EasyBib

(Ris Format - Win & Mac)

Medlars Medlars

(Txt Format - Win & Mac)

Mendeley Web Mendeley Web
Mendeley Mendeley

(Ris Format - Win & Mac)

Papers Papers

(Ris Format - Win & Mac)

ProCite ProCite

(Ris Format - Win & Mac)

Reference Manager Reference Manager

(Ris Format - Win only)

Refworks Refworks

(Refworks Format - Win & Mac)

Zotero Zotero

(Ris Format - FireFox Plugin)

J Renal Inj Prev. 2019;8(3):216-220.
doi: 10.15171/jrip.2019.40
  Abstract View: 100
  PDF Download: 96

Original

Impact of allopurinol on metabolic acidosis in patients with chronic kidney disease; a randomized controlledtrial

Davood Gholami 1, Maryam Hami 2 ORCiD, Boshra Hasanzamani 2 ORCiD, Maryam Miri 2 * ORCiD

1 Mashhad University of Medical Sciences, Mashhad, Iran
2 Kidney Transplantation Complications Research Centre, Mashhad University of Medical Sciences, Mashhad, Iran
*Corresponding author: Maryam Miri, Email: Email: mirighm@mums.ac.ir

Article

Introduction: Chronic kidney disease (CKD) is a disabling disease with multiple complications, like, increased serum levels of uric acid due to glomerular filtration rate (GFR) impairment.

Objectives: This study was designed to evaluate the effect of allopurinol on metabolic acidosis in patients with renal failure.

Patients and Methods: This is a randomized controlled-trial study on 50 patients with CKD stage II-IV, who referred to Qaem and Montaserieh hospitals in Mashhad. Patients were selected and randomly divided into two equal groups of 25 subjects. In addition to standard treatments, the intervention group received 100 mg allopurinol tablet for three months and the control group received placebo. Demographic data were obtained from each individual. Serum uric acid level, creatinine, blood pH and bicarbonate levels were assessed at the initiation of treatment and at the end of the third month.

Results: The mean age of patients was 54.04±12.62 years. Allopurinol administration resulted in a significant increase of serum bicarbonate levels and pH (P<0.001 for each) compared to the control group. A significant reduction in uric acid (P<0.05) and an increase in GFR (P<0.05) was observed in both groups.

Conclusion: Allopurinol could ameliorate metabolic acidosis, glomerular filtration and uric acid in patients with CKD.

Implication for health policy/practice/research/medical education:

In a randomized controlled-trial study on 50 patients with chronic kidney disease stage II-IV, we found, allopurinol could ameliorate metabolic acidosis and glomerular filtration by reducing serum uric acid levels.

Please cite this paper as: Gholami D, Hami H, Hasanzamani B, Miri M. Impact of allopurinol on metabolic acidosis in patients with chronic kidney disease; a randomized controlled-trial. J Renal Inj Prev. 2019; 8(3): 216-220. DOI: 10.15171/jrip.2019.40.

First name
 
Last name
 
Email address
 
Comments
 
Security code


Article Viewed: 100

Your browser does not support the canvas element.


PDF Downloaded: 96

Your browser does not support the canvas element.